Josh Watson

Bachelor of Medicine and Bachelor of Science,  Charité - Universitätsmedizin Berlin 

Location: Germany

Consulting Services

Biostatistics Journal Manuscript Career Advice and Mentoring Research Consulting Pharma-CRO-Device

Areas Of Interest

Novaruca Protease, Cysteine Population Decrease p21(c-Ha-ras) Lice American Mandrakes TREM 1 Protein Overlapping Gene Anticancer Drug Combinations Thioredoxin Disulfide Reductase Sequence Typing, Multilocus guyanenses, Leishmania brasiliensis Chagas' Disease Effects, Convulsant Lissencephalies, Classic Fatty Acid Acyl CoA Oxidase Disease, Sweat Gland Collateral Sensitivity, Drug Saturnine Tremor Earmuffs Stem Cell, Oogonial Anhydrase B, Carbonic Involvement, Community Papilliferum, Hidradenoma Injury, Superficial Head Bilingualism Pupil, Ectopic beta 1 Metal Binding Globulin Effect, Serotonin Agonists, Histamine Lipotes vexillifer Effect, Interviewer Tongue, Blue Ventilations, Single-Lung Oxytetracycline Anhydrous Diabetes, Type 1

Professional Narrative

Dr. Josh Watson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Watson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Executive Director, Amgen 2012
Executive Director, Amgen 2019

Education

Master of Science in physician assistant, Yale School of Medicine 2015
Bachelor of science in nursing, Baylor College 1987

Referees


Publications

Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :